migentra-egypt.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | MiGenTra |
| Description | Toggle navigation About Us Overview History Bio Alliances News In The Media R & D About R & D Departments & Facilities Research Fields Manufacturing Abo |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 212.12.238.77 |
| Location | Egypt |
Related Websites
| Site | Rank |
More to Explore
migentra-egypt.com Valuation
|
US$532,505
Last updated: 2023-05-19 19:42:21
migentra-egypt.com has Semrush global rank of 19,876,454. migentra-egypt.com has an estimated worth of US$ 532,505, based on its estimated Ads revenue. migentra-egypt.com receives approximately 61,443 unique visitors each day. Its web server is located in Egypt, with IP address 212.12.238.77. According to SiteAdvisor, migentra-egypt.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$532,505 |
| Daily Ads Revenue | US$492 |
| Monthly Ads Revenue | US$14,747 |
| Yearly Ads Revenue | US$176,956 |
| Daily Unique Visitors | 4,097 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| migentra-egypt.com. | A | 599 | IP: 212.12.238.77 |
| migentra-egypt.com. | NS | 3600 | NS Record: ns25.domaincontrol.com. |
| migentra-egypt.com. | NS | 3600 | NS Record: ns26.domaincontrol.com. |
HtmlToTextCheckTime:2023-05-19 19:42:21
| Toggle navigation About Us Overview History Bio Alliances News In The Media R & D About R & D Departments & Facilities Research Fields Manufacturing About Manufacturing Mammalian Cell Culture Yeast Cell Culture Quality Portfolio Products Pipeline Publications Careers Contact Us MiGenTra Egypt MiGenTra Egypt is the first R&D and manufacturing biopharmaceutical facility in Egypt, Africa, and the Middle East. The company specializes in the development and manufacturing of therapeutic recombinant proteins with a primary focus on the areas of liver disease, thrombosis and haemostasis, infertility, oncology, as well as rheumatoid arthritis. The company’s first and foremost goal is to provide patients with highly innovative and affordable genetically engineered recombinant drugs with the highest standard of quality. Publications 2018 | Biochemical characterization and immunogenicity of Neureight, a recombinant full-length factor VIII produced by fed-batch process in disposable bioreactors |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 150 Content-Type: text/html; charset=UTF-8 Location: https://migentra-egypt.com/ Server: Microsoft-IIS/8.5 X-Powered-By: ASP.NET Date: Tue, 15 Nov 2022 08:24:43 GMT HTTP/1.1 200 OK Cache-Control: private Content-Length: 30054 Content-Type: text/html; charset=utf-8 Server: Microsoft-IIS/8.5 Set-Cookie: ASP.NET_SessionId=0srh4jryhfufnke5zou0kmtz; path=/; HttpOnly; SameSite=Lax X-AspNet-Version: 4.0.30319 X-Powered-By: ASP.NET Date: Tue, 15 Nov 2022 08:24:43 GMT |
migentra-egypt.com Whois Information
Domain Name: MIGENTRA-EGYPT.COM Registry Domain ID: 2672293625_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-04T07:26:28Z Creation Date: 2022-02-01T14:11:52Z Registry Expiry Date: 2023-02-01T14:11:52Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS25.DOMAINCONTROL.COM Name Server: NS26.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-11-15T08:20:59Z <<< |